Valuation (0%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 13.54 |
| PEG Ratio (TTM) | N/A | 2.64 |
| P/S Ratio (TTM) | N/A | 1.61 |
| P/B Ratio (TTM) | N/A | 2.79 |
| P/FCF Ratio (TTM) | N/A | 7.32 |
| Price to 5YR AVG Earnings Ratio | N/A | 20.89 |
| Price to 5YR AVG FCF Ratio | -17.17 | 11.97 |
Profitability (38%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.74% | 4.51% |
| ROE (TTM) | 15.58% | 21.79% |
| Net Profit Margin (TTM) | 14.75% | 11.53% |
| ROIC 5YR AVG | 0.87% | 10.14% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | -33.33% | -20.00% |
| Revenue | 1.54% | 3.92% | 4.70% |
| Net Income | 18.62% | 64.36% | 242.19% |
| Cash Flow | 165.81% | 22.64% | 129.56% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 22.09 |
| Quick Ratio (TTM) | N/A | 22.09 |
| D/E Ratio (TTM) | 0.10 | 0.38 |
| Interest Coverage (TTM) | 3.01 | 19.68 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 0.47 | 1.66 |
| LTL to 5YR AVG FCF | -5.48 | 1.40 |
| Shares Outstanding Growth 5YR AVG | -20.00% | -2.13% |